LymeX Authorization Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7482 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                                H. R. 7482

 To authorize the Secretary of Health and Human Services to fund prize 
competitions to accelerate innovation in the prevention, diagnosis, and 
           treatment of Lyme disease, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 11, 2026

 Mr. Smith of New Jersey (for himself and Mr. Doggett) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To authorize the Secretary of Health and Human Services to fund prize 
competitions to accelerate innovation in the prevention, diagnosis, and 
           treatment of Lyme disease, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``LymeX Authorization Act''.

SEC. 2. POLICY.

    It is the policy of the United States to--
            (1) engage stakeholders, including academia, nonprofits, 
        industry, small business, entrepreneurs, and government to 
        facilitate patient-centered innovations in Lyme disease care;
            (2) foster breakthroughs in health education and public 
        awareness initiatives focused on Lyme disease patients; and
            (3) accelerate development of next-gen diagnostics that are 
        rapid and patient focused.

SEC. 3. AUTHORIZATION OF APPROPRIATIONS.

    There is authorized to be appropriated to the Secretary of Health 
and Human Services $5,000,000 to carry out prize competitions (as 
defined in section 24 of the Stevenson-Wydler Technology Innovation Act 
of 1980 (15 U.S.C. 3719)) to accelerate innovation in the prevention, 
diagnosis, and treatment of Lyme disease.
                                 <all>